This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Solesence, Inc.
5/12/2026
Good day and thank you for standing by. Welcome to the Soul Essence first quarter 2026 conference call. Today's call is being recorded. On today's call we have Kevin Curitan, President and Chief Executive Officer of Soul Essence and Laura Riffner, Chief Financial Officer of Soul Essence. During this call management will make statements that include forward-looking statements within the meaning of the federal securities laws which are pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. This conference call may contain statements that reflect the company's current beliefs and a number of important factors that could cause actual results for future periods to differ materially from those stated on this call. These important factors include, without limitation, a decision of a customer to cancel purchase order or supply agreements, demand and acceptance of the company's personal care ingredients, advanced materials and formulated products, changes in development and distribution relationships, the impact of competitive products and technology, possible disruption in commercial activities occasioned by public health issues, terrorist activity, an armed conflict, and other risks indicated in the company's filings with the Securities and Exchange Commission. Except as required by federal securities laws, the company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties, or other contingencies. I'll now hand the conference over to Kevin Curitan, President and Chief Executive Officer. Please go ahead, sir.
Thank you, Operator. Welcome everyone to our call today. I'd like to thank our investors for their dedication and belief and our team for their tireless effort in growing the world's most innovative skin health company. As many of you know, over the past six years, we have transformed from a small-scale materials company into a leading developer and manufacturer of SPF-infused beauty products in the United States. The evolution of our company resulted in growth at a compounded annual rate of over 50%, enabled us to uplift to the NASDAQ exchange, and contributed to an increase in our market capitalization of more than 5x. Our growth was not limited to our top line performance. Along with this top line growth, a global patent portfolio was created around consumer preferred products and technologies. These changes in our business model bring new operating complexity as well as exciting new opportunities. The increased operating complexity requires us to significantly modify our business processes to fully capture the value we have created and build the foundation for our next phase of growth. The opportunities allow us to change our service model to increase our ability to capture a greater share of overall market and channel value to more completely gain both the operating margins and enterprise value typically enjoyed by technology-driven companies. In March, we introduced Transform and Transcend to our investor community, the strategic initiative we began at the end of 2025. Transform and Transcend is our structured multi-year initiative designed to transform our operational execution to transcend beyond the traditional CDMO model into a strategic supply-side innovation partner. that drives superior financial performance for both our brand partners and our company. It is focused on aligning our operational performance with the strength of our technology platforms and positioning the business for long-term sustainable profitability and growth. Our performance in the first quarter of 2026 reflects the early stages of our discipline execution against our plan. It is a period of intentional investment organizational realignment, and implementation of new processes and procedures. This is work that we expect will position us for improved operational and financial results as we move through the year. With that context in mind, I'll turn it over to Laura to walk you through our first quarter financial results. Laura?
Thank you, Kevin. For the first quarter of 2026, revenue was $13 million compared to $14.6 million in the first quarter of 2025. As we had guided in the annual earnings call, we had shift and open orders that would have resulted in more comparable year-over-year revenue results, but soft OTIF performance resulted in some delays in shipments. Despite lower revenue, gross margin increased by 300 basis points to 26%. This small but impactful improvement was related to improved labor efficiency and the elimination of product quality related waste that we experienced in Q1 of 2025. As Kevin mentioned, our first quarter results reflect the early stage investments associated with Transform and Transcend, particularly within our operational infrastructure. In the first quarter, we implemented two key changes at the employee level. First, we introduced an updated shift structure. Through this reallocation of our personnel, we are addressing the extended process changeovers and related downtime that were one of the biggest contributors to the elevated labor costs we experienced as we scaled our production volume. To ensure that our personnel also have the knowledge necessary to be as productive as possible, we also invested in training them in this new lean manufacturing structure. While these investments resulted in some near-term pressure on profitability, they are aligned with a clearly defined roadmap to strengthen our operating model and improve our margin profile over time. As a result of these investments and our shipping performance, net income for the first quarter was a loss of $0.8 million compared to net income of $0.08 million in the prior year. Adjusted EBITDA for the first quarter was a loss of $107,000 compared to adjusted EBITDA of positive $609,000 for the first quarter of last year. From a demand perspective, our shift in open orders now total $47 million. While booking trends remain encouraging, this remains aligned with our previously communicated expectations for a more normalized revenue environment in 2026. Our priorities for 2026 remain centered on executing our Transform and Transcend initiative, beginning with operational excellence. This includes... improving inventory management through our SIOP implementation, improving efficiencies across our manufacturing and supply chain processes, and enhancing procurement and working capital discipline. We are reiterating our previously communicated guidance for the year, in which we established a 30% floor for gross profit margins and we remain on track to return to double-digit EBITDA margins by the end of the year as we realize improvements in labor efficiency and the six-figure annual savings from our facility consolidation. I'll now turn it back to Kevin.
You're reading a preview of the SLSN Q1 2026 earnings call.
Free account.